|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/21 | (2006.01) |
| A61K 38/21 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 31/14 | (2018.01) |
| (11) | Patento numeris | 3957319 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21164362.2 |
| Europos patento paraiškos padavimo data | 2017-02-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2022-02-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-12-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662297759 P | 2016-02-19 | US |
| (72) |
MARTINS, Eduardo Bruno , US
|
| (73) |
EIT Pharma, Inc. ,
11620 Wilshire Boulevard
Suite 350, Los Angeles, CA 90025,
US
|
| (54) | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA |
| TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA |